Outcome in Phospholamban R14del Carriers
Ingrid A.W. van Rijsingen(Amsterdam UMC Location University of Amsterdam), Arthur A.M. Wilde(Amsterdam Neuroscience), Imke Christiaans(Academic Medical Center), Eline A. Nannenberg(Amsterdam UMC Location University of Amsterdam), Jan D.H. Jongbloed(University Medical Center Groningen), Aeilko H. Zwinderman(Amsterdam Neuroscience), Paul A. van der Zwaag(University Medical Center Groningen), Hanno L. Tan(Netherlands Heart Institute), Ronald H. Lekanne Deprez(Erasmus University Rotterdam), Richard N.W. Hauer(Johns Hopkins University), Yigal M. Pinto(Amsterdam Neuroscience), Maarten P. van den Berg(Regions Hospital), Jan G. Post, Judith A. Groeneweg(University Medical Center Groningen), J. Peter van Tintelen(Utrecht University), Rudolf A. de Boer(Erasmus MC)
Cited by 190
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k